PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma

被引：158
|
作者：
Paiva, B. [1 ,2 ,3 ]
Azpilikueta, A. [2 ]
Puig, N. [4 ]
Ocio, E. M. [4 ]
Sharma, R. [5 ]
Oyajobi, B. O. [5 ]
Labiano, S. [2 ]
San-Segundo, L. [4 ]
Rodriguez, A. [3 ]
Aires-Mejia, I. [4 ]
Rodriguez, I. [2 ]
Escalante, F. [6 ]
de Coca, A. G. [7 ]
Barez, A. [8 ]
San Miguel, J. F. [1 ,2 ,3 ]
Melero, I. [1 ,2 ,3 ]
机构：
[1] Univ Navarra Clin, Pamplona, Spain
[2] CIMA, Pamplona, Spain
[3] Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain
[4] Hosp Univ Salamanca, IBSAL, IBMCC USAL CSIC, Salamanca, Spain
[5] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[6] Complejo Hosp Leon, Leon, Spain
[7] Hosp Clin Univ Valladolid, Valladolid, Spain
[8] Hosp Nuestra Senora de Sonsoles, Avila, Spain
来源：
LEUKEMIA | 2015年 / 29卷 / 10期
关键词：
ANTIBODY; EXPRESSION; RESPONSES; CELLS;
D O I：
10.1038/leu.2015.79
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2110 / 2113
页数：5
相关论文
共 50 条
  • [1] PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
    B Paiva
    A Azpilikueta
    N Puig
    E M Ocio
    R Sharma
    B O Oyajobi
    S Labiano
    L San-Segundo
    A Rodriguez
    I Aires-Mejia
    I Rodriguez
    F Escalante
    A G de Coca
    A Barez
    J F San Miguel
    I Melero
    [J]. Leukemia, 2015, 29 : 2110 - 2113
  • [2] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    [J]. ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [3] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [4] Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma
    Jelinek, Tomas
    Paiva, Bruno
    Hajek, Roman
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [5] The PD-1: PD-L1 pathway in the context of the osteosarcoma tumor microenvironment
    Koirala, Pratistha
    Gill, Jonathan
    Roth, Michael
    Piperdi, Sajida
    Park, Amy
    Poon, Vincent
    Fremed, Michael
    Hoang, Bang
    Gorlick, Richard
    [J]. CANCER RESEARCH, 2015, 75
  • [6] Toxicities Associated With PD-1/PD-L1 Blockade
    Wang, Daniel Y.
    Johnson, Douglas B.
    Davis, Elizabeth J.
    [J]. CANCER JOURNAL, 2018, 24 (01): : 36 - 40
  • [7] PD-1 and PD-L1 blockade in gastrointestinal malignancies
    Lote, Hazel
    Cafferkey, Catherine
    Chau, Ian
    [J]. CANCER TREATMENT REVIEWS, 2015, 41 (10) : 893 - 903
  • [8] Mechanisms of Resistance to PD-1 and PD-L1 Blockade
    Nowicki, Theodore S.
    Hu-Lieskovan, Siwen
    Ribas, Antoni
    [J]. CANCER JOURNAL, 2018, 24 (01): : 47 - 53
  • [9] PD-1/PD-L1 inhibitors in multiple myeloma: The present and the future
    Jelinek, T.
    Hajek, R.
    [J]. ONCOIMMUNOLOGY, 2016, 5 (12):
  • [10] PD-1/PD-L1 Blockade After Transient Lymphodepletion to Treat Myeloma
    Kearl, Tyce
    Jing, Weiqing
    Johnson, Bryon D.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 730 - 731
12345